ZymoGenetics Inc (ZGEN1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
1201 EASTLAKE AVENUE E SEATTLE, WA 98102

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

ZymoGenetics Inc. engages in the discovery development manufacture and commercialization of therapeutic proteins for the treatment of human diseases in the areas of hemostasis inflammatory and autoimmune diseases cancer and viral infections.

View SEC Filings from ZGEN1 instead.

View recent insider trading info

Funds Holding ZGEN1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZGEN1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRISTOL MYERS SQUIBB CO

ZEUS ACQUISITION CORP

  • 10% Owner
82,605,529 2010-10-08 0

NOVO NORDISK A S

  • FORMER 10% OWNER
No longer subject to file 2010-10-08 0

WILLIAMS DOUGLAS E CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2010-10-08 0

PENHOET EDWARD

  • Director
0 2010-10-08 0

JOHNSON JAMES A EXECUTIVE VP AND CFO

  • Officer
0 2010-10-08 0

CARTER BRUCE L A

  • Director
115,399 2010-10-08 0

HIRSH DAVID I

  • Director
0 2010-10-08 0

NIELSEN KURT ANKER

  • Director
0 2010-10-08 0

HARPER JAMES A

  • Director
0 2010-10-08 0

MACCALLUM DAVID

  • Director
0 2010-10-08 0

HAMBY DARREN R SR. VP, HR & CORP SVCS

  • Officer
0 2010-10-08 0

FRANKLIN HEATHER L SR. VP, BUSINESS DEVELOPMENT

  • Officer
2,500 2010-10-08 0

RAMOS ELEANOR SR. VP, CHIEF MEDICAL OFFICER

  • Officer
2,500 2010-10-08 0

MILLER DENNIS M. SR VP, RESRCH & PRECLIN DEVL

  • Officer
2,500 2010-10-08 0

JORGENSEN LARS FRUERGAARD

  • Director
0 2010-10-08 0

WARBURG PINCUS EQUITY PARTNERS LP

WARBURG PINCUS & CO

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH

  • 10% Owner
No longer subject to file 2010-10-07 0

LEFF JONATHAN S

  • Director
  • 10% Owner
No longer subject to file 2010-10-07 0

MONTGOMERY ALAN BRUCE

  • Director
0 2010-03-10 0

ZARUBY STEPHEN W PRESIDENT

  • Officer
0 2010-01-29 0

HEMBERGER JUDITH A

  • Director
0 2009-06-10 0

SORENSEN LARS REBIEN

  • Director
0 2009-06-10 0

SHEMA SUZANNE M SENIOR VP, GENERAL COUNSEL

  • Officer
0 2009-05-15 0

ONETTO NICOLE SR. VP & CHIEF MEDICAL OFFICER

  • Officer
0 2009-01-30 0

DWYER MICHAEL J SENIOR VP, MARKETING & SALES

  • Officer
0 2009-01-30 0

HIMES VAUGHN B SR. VP, TECHNICAL OPERATION

  • Officer
0 2009-01-30 0

OHRSTROM JAN K SR. VP, BUSINESS DEVELOPMENT

  • Officer
373,536 2006-08-24 0

YOUNG MARK D SR VP, TECHNICAL OPERATIONS

  • Officer
215,848 2006-04-24 0

HENELL FREDRIK SR VP BUSINESS DEVELOPMENT

  • Officer
271,509 2006-04-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments